logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
C

Chinese Clinical Oncology

IF2.5
Papers73
Citations
Journal Papers 73
Publication Date
delete
Efficacy and safety of TAS-102 followed by regorafenib or reverse sequence in later-line treatment of metastatic colorectal cancer: a systematic review and meta-analysis
deleteChinese Clinical Oncology
IF2.5
delete2026-06-30
delete0
PREAI
deleteSapapsap, Bannawich; Champarhorm, Sirapratch; Pongpun, Anchana; Kanchana, Nattapong; Tantivit, Jittipon; Leelakanok, Nattawut
deleteShare
deleteSave
Adjuvant CDK4/6 inhibitors and novel therapies in early breast cancer: lessons from monarchE overall survival data
deleteChinese Clinical Oncology
IF2.5
delete2026-06-30
delete0
PREAI
deleteShimoi, Tatsunori
deleteShare
deleteSave
Network pharmacology of Sijunzi decoction in pancreatic cancer
deleteChinese Clinical Oncology
IF2.5
delete2026-06-30
delete0
PREAI
deleteZheng, Rujia; Chen, Qitai; Zhang, Mengting; Yang, Xishan; Zang, Yi; Zhang, Zhe
deleteShare
deleteSave
Venetoclax with intensive chemotherapy in acute myeloid leukemia
deleteChinese Clinical Oncology
IF2.5
delete2026-05-01
delete0
PREAI
deleteShaver, Logan; Jamy, Omer
deleteShare
deleteSave
A narrative review of the value of immunoinflammatory markers in the prognosis of endometrial carcinoma
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteYin, Xinxin; Zhang, Haoyang; Zhang, Sai
deleteShare
deleteSave
First-line programmed death-1 blockade plus chemotherapy in low programmed cell death ligand 1 esophageal squamous cell carcinoma: beyond a single biomarker
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteKadowaki, Shigenori
deleteShare
deleteSave
Impact of neoadjuvant chemotherapy vs. upfront surgery on survival in early-onset colorectal cancer-a single centre experience
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteSalami, Oluwabukunmi Modupe; Yi, Hao; Liu, Guangyi; Li, Yang
deleteShare
deleteSave
Fos-related antigen 1 is required for Helicobacter pylori-induced inflammatory response in gastric epithelial cells through NF-κB pathway
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteYang, Yang; Shao, Shihe
deleteShare
deleteSave
Is rechallenge with CDK4/6 inhibitors beyond progression reasonable for patients with hormone receptor-positive and HER2-negative advanced breast cancer? -a commentary on the PALMIRA trial
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteShimura, Mai; Mukohara, Toru
deleteShare
deleteSave
Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteAkai, Taro; Yamamichi, Gaku; Miyamoto, Hiroshi
deleteShare
deleteSave
Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectives
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteYin, Jun; Geyer, Susan; Shi, Qian; McComb, Bryan; Henry, Courtney; Metts, Jonathan
deleteShare
deleteSave
Small cell lung cancer: a therapeutic update in the era of immunotherapy and beyond-a narrative review
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteBarba, Andres; Martinez-Recio; Portu, Mikel; Soto-Cambres, Ana Maria; Trujillo, Juan Carlos; Farre, Nuria; Majem, Margarita
deleteShare
deleteSave
Claudin 18.2 testing in gastroesophageal and pancreatobiliary cancers: current status, clinical implications and challenges
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete1
PREAI
deleteLee, Sun Mi; Wang, Huamin
deleteShare
deleteSave
Genome-wide 5-hydroxymethylcytosine in circulating cell-free DNA reflects DNA methylation dynamics for non-invasive detection of early hepatocellular carcinoma
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deletePeng, Junya; Pan, Xu
deleteShare
deleteSave
Short- and long-term outcomes after laparoscopic versus open total gastrectomy for stage 0-I gastric cancer: a multicenter, retrospective analysis
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteZhou, Fangyao; Ye, Zaisheng; Zheng, Chengbin; Zhang, Zhaojun; Xiong, Wenjun; Wang, Junjiang; Hu, Weixian; Zheng, Jiabin; Luo, Bin; Wang, Wei; Li, Yong; Chen, Luchuan; Feng, Xingyu
deleteShare
deleteSave
Benign metastasizing leiomyoma: a systematic review of diagnosis, management, and outcomes
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteKaron, Karolina; Szczesny, Natalia; Piatkowski, Krzysztof; Bornio, Ewelina; Grabowski, Wojciech; Plata, Hanna; Palatynska, Monika; Karon, Lukasz; Piatek, Szymon
deleteShare
deleteSave
Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteDel Giglio, Auro
deleteShare
deleteSave
First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteTakahashi, Yuko; Nakamoto, Shogo; Tanioka, Maki; Shien, Tadahiko
deleteShare
deleteSave
Eribulin and trastuzumab in early-line HER2-positive metastatic breast cancer: evaluating an active chemotherapy partner in an evolving treatment landscape
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteChang, Hannah L.; Kang, Irene M.; Rugo, Hope S.
deleteShare
deleteSave
Targeting metabolism in acute myeloid leukemia: the next therapeutic frontier?
deleteChinese Clinical Oncology
IF2.5
delete2026-04-30
delete0
PREAI
deleteMina, Alain; Zeidan, Amer M.
deleteShare
deleteSave